Better Understanding of the Neuroprotective Mechanisms of Korean Ginseng in Strok

更好地了解高丽参对中风的神经保护机制

基本信息

  • 批准号:
    8543642
  • 负责人:
  • 金额:
    $ 45.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-30 至 2017-09-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Better Understanding of the Neuroprotective Mechanisms of Korean Ginseng in Stroke It has been postulated that the determinants of neuronal cell death in acute and chronic neurodegenerative conditions are mediated by free radical damage. Ginseng has been reported to be neuroprotective and a potential preventive medicine, but the underlying cellular mechanisms are still unclear. Our preliminary results prompted us to focus our attention on Korean Ginseng and test the hypothesis that the transcriptional factor Nrf2 could participate in the overall Ginseng's neuroprotective function. HO, which cleaves heme (a prooxidant) to form biliverdin/bilirubin (antioxidants), carbon monoxide (a vasodilator), and iron (a prooxidant) has been shown to play a protective role in oxidative stress, ischemia, inflammation, and hypertension. Although HO2 is constitutively expressed, HO1 is inducible. Consequently, a possible way to increase HO levels to achieve neuroprotection may be to induce HO1. Of the compounds tested in our preliminary experiments in primary neuronal cultures, Ginseng was one of the most potent HO1 inducers. Our results also indicate that pretreatment of neurons with Ginseng is sufficient to provide neuroprotection, suggesting that co-treatment during oxidative stress is not necessary. This neuroprotective effect was abolished by a protein synthesis inhibitor, and was greatly reduced by an HO inhibitor. These preliminary results implied that specific induction of HO1 could be a mechanism by which Ginseng exerts its preventive neuroprotective actions and motivated us to propose that some of the neuroprotective effects attributed to Ginseng could be mediated through HO1 induction and the associated beneficial actions of heme degradation. Recently, we and others have described Nrf2 has as a key regulator of inflammation and redox homeostasis. In Aim 1, we will determine anatomical and behavioral outcomes following ischemia in wild type mice pre-treated (acutely or chronically) with Ginseng, determine whether the beneficial effect is sustained with aging, and test whether these effects are attenuated in Nrf2 knockout mice. In Aim 2, we will determine whether Ginseng induced characteristic changes in brain cells, and start addressing in which cell types these Nrf2 changes occurs. Together, these in vivo results will help us determine whether oral consumption of a standardized Ginseng extract could be beneficial, and which cells can be most associated with the Ginseng preventive brain mechanistic pathways by which Ginseng would provide the cell/brain with resistance to acute debilitating neurodegenerative conditions.
描述(申请人提供):更好地了解韩国人参在中风中的神经保护机制据推测,在急性和慢性神经退行性疾病中,神经细胞死亡的决定因素是由自由基损伤介导的。据报道,人参具有神经保护作用和潜在的预防药物作用,但其潜在的细胞机制仍不清楚。我们的初步结果促使我们将注意力集中在韩国人参上,并测试了转录因子Nrf2可能参与人参整体神经保护功能的假设。HO分解血红素(一种促氧化剂)形成胆绿素/胆红素(抗氧化剂)、一氧化碳(一种血管扩张剂)和铁(一种促氧化剂),已被证明在氧化应激、缺血、炎症和高血压中发挥保护作用。虽然HO2是结构性表达的,但HO1是可以诱导表达的。因此,增加HO水平以实现神经保护的一种可能方法可能是诱导HO1。在我们在原代神经元培养的初步实验中测试的化合物中,人参是最有效的HO1诱导剂之一。我们的结果还表明,人参对神经元的预处理足以提供神经保护,这表明氧化应激期间的共同处理是不必要的。这种神经保护作用被蛋白质合成抑制剂消除,并被HO抑制剂大大减弱。这些初步结果表明,HO1的特异性诱导可能是人参发挥预防性神经保护作用的一种机制,并促使我们提出人参的一些神经保护作用可能是通过HO1诱导和与之相关的血红素降解的有益作用来介导的。最近,我们和其他人将Nrf2描述为炎症和氧化还原动态平衡的关键调节因子。在目标1中,我们将确定人参预先(急性或慢性)处理的野生型小鼠缺血后的解剖学和行为结果,确定这种有益作用是否随着年龄的增长而持续,并在Nrf2基因敲除小鼠中测试这些影响是否减弱。在目标2中,我们将确定人参是否诱导了脑细胞的特征变化,并开始研究这些Nrf2变化发生在哪些细胞类型中。总之,这些体内结果将帮助我们确定口服标准化人参提取物是否有益,以及哪些细胞与人参预防性脑机制途径最相关,人参通过这些途径为细胞/大脑提供对急性衰弱神经退行性疾病的抵抗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sylvain DORE其他文献

Sylvain DORE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sylvain DORE', 18)}}的其他基金

Testing brain penetrant iron chelators and investigating putative clearance pathway in ICH
测试脑渗透铁螯合剂并研究 ICH 中假定的清除途径
  • 批准号:
    10201369
  • 财政年份:
    2020
  • 资助金额:
    $ 45.58万
  • 项目类别:
Potential stroke therapeutic efficacy of FumET-CORM through the Nrf2 pathway
FumET-CORM 通过 Nrf2 通路的潜在中风治疗功效
  • 批准号:
    9751526
  • 财政年份:
    2019
  • 资助金额:
    $ 45.58万
  • 项目类别:
Regulation and Implication of Hemoglobin Clearance in Subarachnoid Hemorrhagic Patients
蛛网膜下腔出血患者血红蛋白清除率的调节及意义
  • 批准号:
    9332485
  • 财政年份:
    2016
  • 资助金额:
    $ 45.58万
  • 项目类别:
Regulation and Implication of Hemoglobin Clearance in Subarachnoid Hemorrhagic Patients
蛛网膜下腔出血患者血红蛋白清除率的调节及意义
  • 批准号:
    9182501
  • 财政年份:
    2016
  • 资助金额:
    $ 45.58万
  • 项目类别:
Better Understanding of the Neuroprotective Mechanisms of Korean Ginseng in Strok
更好地了解高丽参对中风的神经保护机制
  • 批准号:
    9128625
  • 财政年份:
    2012
  • 资助金额:
    $ 45.58万
  • 项目类别:
Better Understanding of the Neuroprotective Mechanisms of Korean Ginseng in Strok
更好地了解高丽参对中风的神经保护机制
  • 批准号:
    8708765
  • 财政年份:
    2012
  • 资助金额:
    $ 45.58万
  • 项目类别:
Better Understanding of the Neuroprotective Mechanisms of Korean Ginseng in Strok
更好地了解高丽参对中风的神经保护机制
  • 批准号:
    8369356
  • 财政年份:
    2012
  • 资助金额:
    $ 45.58万
  • 项目类别:
Stilbene's Contribution in Hemorrhagic Stroke
二苯乙烯在出血性中风中的作用
  • 批准号:
    8059681
  • 财政年份:
    2010
  • 资助金额:
    $ 45.58万
  • 项目类别:
Effect of Flavanol-Rich Cocoa Extract in Acute Neurodegenerative Conditions
富含黄烷醇的可可提取物对急性神经退行性疾病的作用
  • 批准号:
    8117138
  • 财政年份:
    2010
  • 资助金额:
    $ 45.58万
  • 项目类别:
Effect of Flavanol-Rich Cocoa Extract in Acute Neurodegenerative Conditions
富含黄烷醇的可可提取物对急性神经退行性疾病的作用
  • 批准号:
    7989678
  • 财政年份:
    2010
  • 资助金额:
    $ 45.58万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 45.58万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.58万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 45.58万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.58万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 45.58万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.58万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 45.58万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 45.58万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 45.58万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.58万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了